Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice-Reference-Cited by-同舟云学术

Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice

Published:2011-07-25 Issue:5 Volume:54 Page:1620-1630
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Li Liang,Chen Lei,Hu Liang,Liu Yuan,Sun Han-Yong,Tang Jing,Hou Yu-Jie,Chang Yan-Xin,Tu Qian-Qian,Feng Gen-Sheng,Shen Feng,Wu Meng-Chao,Wang Hong-Yang

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24552/fullpdf

Reference32 articles.

1. Steatohepatitis: a tale of two “hits”?;Day;Gastroenterology,1998

2. From fat to inflammation;Day;Gastroenterology,2006

3. Toll-like receptor signaling;Akira;Nat Rev Immunol,2004

4. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein;Park;J Biol Chem,2004

5. Toll-like receptors and cancer;Rakoff-Nahoum;Nat Rev Cancer,2009

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of protein partners for small molecules reshapes the understanding of nonalcoholic steatohepatitis and drug discovery;Life Sciences;2024-11

2. Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome;AMB Express;2024-08-02

3. RG-I pectin-like polysaccharide from Rosa chinensis inhibits inflammation and fibrosis associated to HMGB1/TLR4/NF-κB signaling pathway to improve non-alcoholic steatohepatitis;Carbohydrate Polymers;2024-08

4. Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH;Hepatology Communications;2024-06-27

5. Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications;Biomedicine & Pharmacotherapy;2024-06